- Who we areWho we are
We are a biotechnology company committed to helping address serious infectious diseases globally through the discovery and development of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
- What we doWhat we do
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
Latest UpdatesStay current with Novavax news as we make progress in discovering and developing innovative vaccines to help protect against serious infectious diseases.
- Blog
Novavax Chief Corporate Affairs and Advocacy Officer Appointed to Maryland Tech Council Board
Novavax today announced that Silvia Taylor, Chief Corporate Affairs and Advocacy Officer, has been elected to the Maryland Technology Council (MTC) Board of Directors. Ms. Taylor succeeds John Trizzino, Novavax Executive Vice President, Chief Commercial Officer and Chief Business Officer, who served for the past eight years as a member of the MTC Board.
Novavax has been a proud member of MTC since 2006, sharing the Council’s goal to protect and improve the lives of people everywhere through innovation while helping advance MTC’s vision to propel Maryland to “become the number one innovation economy for life sciences and technology in the country.”
